Monthly Prescribing Reference
UPDATE 2-Novo launches Saxenda in US, sees more launches in 2015
(Adds drug price, analyst's comment). COPENHAGEN, April 22 (Reuters) - Novo Nordisk has launched its Saxenda obesity drug in the United States, it said on Wednesday, a long-awaited milestone that will provide a new revenue stream for the Danish ...
Eyeing big niche in obesity, Novo rolls out Saxenda at $1000 per month
Novo launches Saxenda in US, sees more launches in 2015
Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now ...
by via Health - Google News